These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21656743)

  • 1. Correlation of LAPTM4B polymorphisms with cervical carcinoma.
    Meng F; Song H; Luo C; Yin M; Xu Y; Liu H; Zhou R; Lou G
    Cancer; 2011 Jun; 117(12):2652-8. PubMed ID: 21656743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Wang B; Xu J; Zhou R; Zhang Q
    Med Oncol; 2013 Mar; 30(1):470. PubMed ID: 23345117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
    Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.
    Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
    Med Oncol; 2012 Dec; 29(4):2809-13. PubMed ID: 22302286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
    Liu Y; Zhang QY; Qian N; Zhou RL
    Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.
    Cheng XJ; Xu W; Zhang QY; Zhou RL
    Ann Oncol; 2008 Mar; 19(3):527-32. PubMed ID: 17965115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
    Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
    Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of LAPTM4B gene polymorphism with breast cancer susceptibility.
    Fan M; Liu Y; Zhou R; Zhang Q
    Cancer Epidemiol; 2012 Aug; 36(4):364-8. PubMed ID: 22270081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.
    Zhai G; Yang H; Ji X; Xiong F; Su J; McNutt MA; Li X
    Med Oncol; 2012 Dec; 29(4):2744-9. PubMed ID: 22207410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer.
    Wang S; Zhang QY; Zhou RL
    Ann Oncol; 2012 Jul; 23(7):1864-9. PubMed ID: 22156622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
    Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
    Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis.
    Mo C; Lu Y; Deng Y; Wang J; Xie L; Li T; He Y; Peng Q; Qin X; Li S
    BMC Genet; 2014 Apr; 15():48. PubMed ID: 24746178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
    Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
    PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population.
    Hashemi M; Amininia S; Ebrahimi M; Hashemi SM; Yousefi J; Eskandari-Nasab E; Taheri M; Ghavami S
    Med Oncol; 2014 Aug; 31(8):111. PubMed ID: 25001088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
    Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
    PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer].
    Deng LJ; Zhang QY; Liu B; Zhou RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):302-5. PubMed ID: 15968325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis.
    Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hu W
    Oncol Rep; 2014 May; 31(5):2454-60. PubMed ID: 24676601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
    Meng F; Tan S; Liu T; Song H; Lou G
    Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
    Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
    PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.
    Li Y; Tan SQ; Ma QH; Li L; Huang ZY; Wang Y; Li SW
    Tumour Biol; 2013 Dec; 34(6):3561-7. PubMed ID: 23794133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.